Advertisement

Organisation › Details
WuXi AppTec Inc.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient, socially responsible and sustainable solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec’s open-access platform is enabling more than 4,100 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that “every drug can be made and every disease can be treated.” *
![]() |
Start | 2008-01-01 merged |
Group | WuXi PharmaTech (Group) | |
![]() |
Industry | pharma services |
Industry 2 | contract manufacturing (biologicals) | |
![]() |
Region | Shanghai |
Country | China | |
City | n. a. Shanghai | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Quanterix Corporation. (2/12/21). "Press Release: Quanterix Announces Simoa Joint Laboratory with WuXi AppTec". Billerica, MA. | ||
Record changed: 2024-08-24 |
Advertisement

More documents for WuXi PharmaTech (Group)
- [1] Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel....
- [2] Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried....
- [3] WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai....
- [4] Genezen, Inc.. (1/26/22). "Press Release: Genezen Appoints Senior Director of Business Development"....
- [5] Bristol-Myers Squibb Company. (8/3/21). "Press Release: Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland". New York, NY....
- [6] Metrion Biosciences Ltd.. (7/26/21). "Press Release: Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development". Cambridge....
- [7] WuXi AppTec. (7/20/21). Web Page: WuXi Global Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
- [8] WuXi AppTec. (7/20/21). Web Page: WuXi Healthcare Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
- [9] Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford....
- [10] Almirall S.A.. (1/9/20). "Press Release: Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases". Barcelona....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top